D.E. Shaw & Co
ASMB icon

D.E. Shaw & Co’s Assembly Biosciences ASMB Stock Holding History

D.E. Shaw & Co’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,206
Closed -$435K – 3898
2020
Q3 		$435K Buy
+2,206
New +$556K ﹤0.01% 3289
2020
Q1 		– Sell
-11,924
Closed -$2.93M – 3909
2019
Q4 		$2.93M Sell
11,924
-8,132
-41% -$1.5M ﹤0.01% 2168
2019
Q3 		$2.37M Buy
20,056
+15,632
+353% +$2.36M ﹤0.01% 2232
2019
Q2 		$716K Buy
+4,424
New +$841K ﹤0.01% 2876
2017
Q4 		– Sell
-856
Closed -$359K – 3565
2017
Q3 		$359K Buy
+856
New +$262K ﹤0.01% 3072
2016
Q2 		– Sell
-2,077
Closed -$125K – 3329
2016
Q1 		$125K Buy
2,077
+835
+67% +$55.8K ﹤0.01% 3261
2015
Q4 		$112K Buy
+1,242
New +$135K ﹤0.01% 3662
2014
Q3 		– Sell
-745
Closed -$59K – 4090
2014
Q2 		$59K Buy
+745
New +$52.8K ﹤0.01% 4103

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

D.E. Shaw & Co's ASMB Position: Q4 2020 in Review

D.E. Shaw & Co sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 2,206 shares — an estimated $435K sold.

D.E. Shaw & Co first reported a position in ASMB in Q2 2014 and held it in 8 quarters. The position peaked at $2.93M in Q4 2019. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • D.E. Shaw & Co reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,206 Assembly Biosciences shares in Q4 2020, an estimated $435K.
  • D.E. Shaw & Co first reported a position in Assembly Biosciences in Q2 2014 and held it in 8 quarters.
  • D.E. Shaw & Co's Assembly Biosciences position peaked at $2.93M in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.